Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders.
Snyder GL, Li P, Martin T, Zhang L, Yao W, Zheng H, Maguire DR, Gerak LR, Vanover KE, France CP, Davis R.
Snyder GL, et al. Among authors: zhang l.
Psychopharmacology (Berl). 2024 May 6. doi: 10.1007/s00213-024-06578-w. Online ahead of print.
Psychopharmacology (Berl). 2024.
PMID: 38710856